drugset / Trial / NCT00275197

A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)

NCT00275197

Phase 2 Completed 262 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The major purpose of the study is to help determine whether giving the combination of Elzasonan with Zoloft to people with depression is a better treatment than taking Zoloft alone. This study will also compare the safety and tolerability of Elzasonan and Zoloft combination to Zoloft alone or placebo.

Timeline

Start
2005-12
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Elzasonan Small molecule
Subject Sertraline Small molecule